Welcome To Iconocast

How to add a URL link from your web site to the Iconocast web sites

Virtual tour of Southern California

Recent News and Articles on the Keywords: inhibiting + brain + blood  Related to the article below (Last Update: 8/5/2008)

Oneindia Drug Combo May Improve Cancer Oneindia, India - A combination of drugs inhibiting receptor tyrosine kinases (RTKs) proteins, critical to cancer progression and another targeting inhibitors of apoptosis ... Drug combo may improve cancer therapy efficacy Newstrack India all 5 news articles » Malaysia Star The science of energy healing Malaysia Star, Malaysia - Aug 2, 2008 When the inhibiting ?qi? was emitted, the infrared wave was absorbed from the environment, resulting in a cooling of the air. The biochemical effects of ... News In Brief New University Online, CA - ... the memory center of the brain. In tests, scientists found that inhibiting the NPS receptors prolonged traumatic responses while activating the ... Suicide's genetic key discovered Globe and Mail, Canada - Jul 31, 2008 As a result of the change, the gene shuts down and malfunctions, inhibiting the individual's ability to handle stress and cope with anxiety. ... Alzheimer's disease A tangled tale Economist, UK - Jul 31, 2008 John Ronald, of the University of Western Ontario, and his colleagues have managed to identify the brain plaques associated with the disease using magnetic ... dBTechno Intellect Neurosciences, Inc. Obtains Pivotal European Patent ... MarketWatch - Jul 31, 2008 An accumulation of beta amyloid protein fragments in the brain is thought to be the root cause of Alzheimer's disease. The fragments are generated as a ... Drugs to reverse Alzheimer's disease prove elusive Los Angeles Times all 299 news articles »  OTC:ILNS - OTC:CMTX Seasonal Programmed Brain Cell Death Foiled In Living Birds Science Daily (press release) - Jul 9, 2008 It is the first time scientists have shown that inhibiting an enzyme involved in programmed cell death can protect a brain region in a living animal from ... Having a Baby: Infant?s Smile Works on Mom?s Brain New York Times, United States - Jul 21, 2008 By NICHOLAS BAKALAR Using a functional MRI scanner to watch the brain in action, researchers have demonstrated that a picture of her own smiling baby ... Amyloid beta mAb shows safety and perhaps efficacy in Alzheimer's ... Medicexchange, UK - It has an indirect effect on plaque formation by inhibiting A-beta protein. This increased clearance of A-beta prevents plaque formation," Dr. Siemers ... Genaera Releases Phase 1 Data and New Preclinical Data on the CNS ... Trading Markets (press release), CA - Jul 25, 2008 Previous studies had shown that MSI-1436 is a reversible, noncompetitive inhibitor of PTP1B with the ability to cross the blood brain barrier. ...GENR - OTC:CMTX

Inhibiting Blood to Save the Brain

UCSD researchers suppress relapsing paralysis in mouse model of Multiple Sclerosis

March 22, 2007

By Debra Kain

A fibrous protein called fibrinogen, found in circulating blood and important in blood clotting, can promote multiple sclerosis (MS) when it leaks from the blood into the brain, triggering inflammation that leads to MS-related nerve damage. Researchers at the University of California , San Diego (UCSD) School of Medicine have identified a fibrin-derived peptide that inhibits this specific inflammation process in mouse models of MS, reducing MS symptoms.

“Current strategies to develop therapies to fight MS primarily target T cells,” said Katerina Akassoglou, Ph.D., assistant professor in UCSD’s Department of Pharmacology, whose study was published in the March 19 issue of Journal of Experimental Medicine.   “Blood proteins have been neglected as a therapeutic target, but this research shows that a blood clotting factor is an important player in MS.”  

Article continues below and (thank you)

MS is an inflammatory disease that affects the central nervous system, causing symptoms such as loss of balance and muscle coordination, and changes in cognitive function. The disease is marked by loss of myelin, a material that coats nerve fibers.  Past studies showed that the destruction of the myelin sheath is associated with the accumulation of fibrinogen deposits in the brain of human MS patients. In this study, Akassoglou and colleagues showed that fibrinogen is not merely associated with the damage in MS, but an active participant.  Fibrinogen activates macrophage cells in the brain called microglia, causing inflammation which damages myelin.

The scientists sought to design a therapeutic strategy that would block the damaging effects of fibrinogen without affecting its beneficial blood coagulation.  Studying a mouse model, the researchers identified a specific receptor called Mac-1 that is expressed by microglial cells and binds to fibrinogen.  Mice expressing a mutant form of fibrinogen that failed to bind Mac-1 had fewer inflammatory lesions and less severe MS symptoms.  Blocking the interaction between Mac-1 and fibrinogen after the first episode of paralysis using the fibrin peptide prevented subsequent relapses.  It also prevented further microglia activation and damage to myelin in the diseased mice, allowing them to survive with improved motor function.

“Importantly, this approach blocks fibrin’s interaction with microglia, but not with platelets, so clotting wouldn’t be impacted,” said Akassoglou, adding that this potential MS therapy might also have applications to other blood-brain barrier diseases where blood leakage and microglia activation is present such as spinal cord injury, Alzheimer’s disease or stroke.

Additional contributors to the paper include Ryan A. Adams, Shoana L. Sikorski and Tal Nuriel of UCSD’s Department of Pharmacology; Jan Bauer and Hans Lassmann, Center for Brain Research, Medical University of Vienna; and Matthew J. Flick and Jay L. Degen, Children’s Hospital Research Foundation and University of Cincinnati College of Medicine.

Funding for the study was provided in part by the National Institute for Neurological Disorders and Stroke, part of the National Institutes of Health, and by the National Multiple Sclerosis Society.

Media Contact: Debra Kain, 619-543-6163